Despite several medical therapies currently available to treat Crohn disease, many patients still undergo surgical treatment. Benjamin Cohen, MD, co-section head and clinical director of the Department of...
In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...
In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...
In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...
In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...
In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...
In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
